Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Bioasis Technologies Inc. BIOAF OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bioasis Technologies Inc. (BIOAF) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is -45.6% (-145.6 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 67/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

BIOAF SharesGrow Score Overview

50/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BIOAF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
BIOAF: +124.5%/yr revenue is, -102.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
BIOAF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
67/100
Balance sheet BIOAF: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.0004
Volume72.94K
Avg Volume (30D)16
Market Cap$7.94K
Beta (1Y)1.74
Share Statistics
Shares Outstanding$78.21M
IPO Date2010-12-31
CEODeborah Ann Rathjen
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA09064N1033

Price Chart

Track all markets on TradingView
BIOAF
Bioasis Technologies Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.00

People Also View

CMVLF
CMVLF
Cellectis S.A.
$3.08
-30.00%
 FENC
FENC
Fennec Pharmaceuticals Inc.
$6.25
+5.40%
 CVALF
CVALF
Covalon Technologies Ltd.
$1.45
+0.69%
 BITRF
BITRF
Biotron Limited
$0.03
+0.00%
 ZHCLF
ZHCLF
Zenith Capital Corp.
$0.11
-22.22%
 PMN
PMN
ProMIS Neurosciences, Inc.
$12.05
-6.73%
 HOPHF
HOPHF
Hemogenyx Pharmaceuticals Plc
$2.33
+0.00%
 CRPOF
CRPOF
Ceapro Inc.
$0.17
-13.04%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message